Article
Simultaneous integrated boost noninferior to sequential boost in phase 3 in early BC
Article
HR+/ERBB2+ early BC: Excellent pCR rate with de-escalated neoadjuvant paclitaxel plus trastuzumab and pertuzumab
Article
Phase 3 shows promising activity of capivasertib-fulvestrant combo in HR+/HER2− advanced BC
Article
Atopic dermatitis shortens biologic-free survival in inflammatory bowel disease
Article
Dupilumab ameliorates disease signs and symptoms in children with severe atopic dermatitis
Article
Meta-analysis reveals that abrocitinib and upadacitinib top dupilumab in moderate-to-severe atopic dermatitis
Article
Early emollient use does not lower the odds of atopic dermatitis in high-risk infants
News
Electronic nose may sniff out early lung cancer in COPD
Molecular profiling of exhaled breath using electronic nose (eNose) technology has shown potential as a method of early detection by identifying...